Antibodies
24 November 2008
Medarex Announces Initiation of Phase 1b Clinical Development Program with MDX-1106 for the Treatment of Cancer24 November 2008
Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects23 November 2008
Avastin Plus Commonly Used Chemotherapies Demonstrated Improved Progression-Free Survival In Advanced Breast Cancer21 November 2008
CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients21 November 2008
RoActemra Receives Positive Opinion in Europe for the Treatment of Rheumatoid Arthritis20 November 2008
Biovitrum and Symphogen Report Positive Clinical Results in Novel Rh- immunization Prevention Project19 November 2008
Randomized Phase 2 Study of IMC-A12 for HER2-Expressing Advanced Breast Cancer Commences Patient Enrollment18 November 2008
Genentech Issues Dear Healthcare Provider Letter Regarding a 2nd Case of PML in a Raptiva Patient18 November 2008
Cimzia(R) studies show significant clinical benefits for mono- and combination therapy in patients with rheumatoid arthritis17 November 2008
Life Science Pharmaceuticals Enters Into Agreement with Abbott to Develop Antibody 80611 November 2008
Phase 2 Study of IMC-1121B in First-Line Treatment of Advanced Non-Small Cell Lung Cancer Commences Patient Enrollment10 November 2008
Ophthotech Treats First Patient in a Phase I Trial of Monoclonal Antibody, Volociximab, for Age-Related Macular Degeneration7 November 2008
InNexus Biotechnology Announces New EGFR Antibody DXL1218 Targeting Colorectal Cancer and Announces $1.25 Million Private Placement3 November 2008
Genentech Submits Application to U.S. Food and Drug Administration for Avastin in the Most Aggressive Form of Brain Cancer1 November 2008
GlobeImmune Hepatitis C Therapeutic Vaccine, GI-5005, Doubles Viral Clearance and Increases RVR Rates in Phase 2 Clinical Trial30 October 2008
New Cimzia(R) study shows rapid reduction of symptoms and progression of rheumatoid arthritis30 October 2008
Biogen Idec Elects to Participate with Genentech in the Development and Commercialization of a Next Generation Anti-CD20 Molecule29 October 2008
Phase 2a Data for MEDI-528 Presented at CHEST 200829 October 2008
Merck KGaA and Lpath Form Alliance for ASONEPNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports